FIELD: medicine.
SUBSTANCE: invention relates to high stable pharmaceutical component containing peptide of human parathyroid hormone or derivative thereof and acetic acid in amount of less than chemical equivalent in relates to peptide of human parathyroid hormone or derivative thereof. Due to low acetic acid level obtained pharmaceutical compositions have high stability and are comfortable in application.
EFFECT: nasal compositions with increased stability.
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2737264C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF NALOXONE HYDROCHLORIDE-BASED NASAL SPRAY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2572217C2 |
| LOXOPROFEN-CONTAINING PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTIONS | 2001 |
|
RU2232572C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF DODECAPEPTIDE INGRAMON | 2022 |
|
RU2793124C1 |
| ZOLMITRIPTAN-CONTAINING PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2255736C2 |
| LIQUID PREPARATION CONTAINING CAMPTOTHECIN DERIVATIVE AND PHARMACEUTICAL COMPOSITION PREPARED BY LYOPHILIZATION OF PREPARATION | 2003 |
|
RU2315623C2 |
| HUMAN PARATHYROID HORMONE (PTH) FORMULATIONS AND METHODS FOR PREPARING THEREOF | 2020 |
|
RU2820316C1 |
| PHARMACEUTICAL GEL COMPOSITION FOR TREATMENT OF DISEASES, METHOD FOR OBTAINING SAME AND RESPECTIVE KIT | 2003 |
|
RU2333743C2 |
| ORAL PHARMACEUTICAL COMPOSITION OF DESMOPRESSIN | 2008 |
|
RU2474414C2 |
